Skip to main content

Grafa News and Videos — Page 1644

Latest

Grafa

Kiora Pharmaceuticals secures long-term cash runway as dual retinal trials advance

Kiora Pharmaceuticals (NASDAQ:KPRX) released its fourth-quarter and full-year 2025 financial results on Wednesday, detailing a streamlined balance sheet and steady clinical momentum for its pipeline of retinal disease treatments.

Read more: Kiora Pharmaceuticals secures long-term cash runway as dual retinal trials advance
Grafa
Technology

Honeywell secures $500M framework deal with U.S. Department of War to scale defense production

Honeywell Aerospace (NASDAQ:HON) entered into a landmark supplier framework agreement with the U.S. Department of War on March 25, 2026, marking a significant escalation in the company’s defense manufacturing footprint.

Read more: Honeywell secures $500M framework deal with U.S. Department of War to scale defense production
Grafa

ADMA Biologics rebuts short seller report, labeling claims misleading

ADMA Biologics (NASDAQ:ADMA), a U.S.-based commercial biopharmaceutical company specializing in the manufacture and marketing of specialty biologics, issued a formal statement on Wednesday addressing a critical report published on March 24, 2026, by Culper Research.

Read more: ADMA Biologics rebuts short seller report, labeling claims misleading

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift